Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Wells Fargo Maintains Equal-Weight on Pfizer, Raises Price Target to $30

Author: Benzinga Newsdesk | July 31, 2024 12:07pm
Wells Fargo analyst Mohit Bansal maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $28 to $30.

Posted In: PFE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist